Related references
Note: Only part of the references are listed.Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b-4 CKD
Pablo E. Pergola et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
Michael B. Sporn et al.
JOURNAL OF NATURAL PRODUCTS (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1
Qing Qing Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease
Cliona Stack et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action
Ghada A. Soliman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Leprdb/db Mice
Pradip K. Saha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Blueprint for antimicrobial hit discovery targeting metabolic networks
Y. Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration
Marisol Cano et al.
VISION RESEARCH (2010)
The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in Mice
Narsa M. Reddy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
Hiroyuki Mori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice
Karen Liby et al.
CANCER PREVENTION RESEARCH (2009)
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
Melinda S. Yates et al.
CARCINOGENESIS (2009)
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Wilfred Lieberthal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth
Hugo A. Acosta-Jaquez et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The impact of cellular networks on disease comorbidity
Juyong Park et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
STRING 8-a global view on proteins and their functional interactions in 630 organisms
Lars J. Jensen et al.
NUCLEIC ACIDS RESEARCH (2009)
Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
Lichuan Yang et al.
PLOS ONE (2009)
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
Thomas E. Sussan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oleanane Triterpenoid CDDO-Me Inhibits Growth and Induces Apoptosis in Prostate Cancer Cells by Independently Targeting Pro-Survival Akt and mTOR
Dorrah Deeb et al.
PROSTATE (2009)
A Dynamic Network Approach for the Study of Human Phenotypes
Cesar A. Hidalgo et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Synthetic Triterpenoids Attenuate Cytotoxic Retinal Injury: Cross-talk between Nrf2 and PI3K/AKT Signaling through Inhibition of the Lipid Phosphatase PTEN
Ian Pitha-Rowe et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Triterpenoid CDDO-methyl ester inhibits the janus-activated kinase-1 (JAK1)→Signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3
Rehan Ahmad et al.
CANCER RESEARCH (2008)
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268
Karen Liby et al.
CLINICAL CANCER RESEARCH (2008)
Role of TSC-mTOR pathway in diabetic nephropathy
Ken Inoki
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor β-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex
Ciric To et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methy amide are more potent than efttinb for prevention of mouse lung carcinogenesis
Karen Liby et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib
Oliver Hantschel et al.
LEUKEMIA & LYMPHOMA (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice
William O. Osburn et al.
TOXICOLOGICAL SCIENCES (2008)
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent
Nicola Vannini et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Platforms and networks in triterpenoid pharmacology
Michael B. Sporn et al.
DRUG DEVELOPMENT RESEARCH (2007)
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Karen T. Liby et al.
NATURE REVIEWS CANCER (2007)
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice
Karen Liby et al.
CANCER RESEARCH (2007)
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry
Joshua E. Elias et al.
NATURE METHODS (2007)
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes
Melinda S. Yates et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-κB activation through direct inhibition of IκB kinase β
Mark M. Yore et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179
Rehan Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AgBase: a functional genomics resource for agriculture
Fiona M. McCarthy et al.
BMC GENOMICS (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells
Karen Liby et al.
CLINICAL CANCER RESEARCH (2006)
Transcriptional regulation via cysteine thiol modification: A novel molecular strategy for chemoprevention and cytoprotection
Hye-Kyung Na et al.
MOLECULAR CARCINOGENESIS (2006)
2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: A possible mechanism contributing to apoptosis
RD Couch et al.
MOLECULAR PHARMACOLOGY (2006)
A synthetic triterpenoid, CDDO-Me, inhibits IκBα, kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor κB-regulated gene products in human leukemic cells
S Shishodia et al.
CLINICAL CANCER RESEARCH (2006)
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole
MS Yates et al.
CANCER RESEARCH (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling
K Liby et al.
CANCER RESEARCH (2005)
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
ML Hyer et al.
CANCER RESEARCH (2005)
Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action
RD Couch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance
D Chauhan et al.
BLOOD (2004)
Design, synthesis, and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia
M Konopleva et al.
CANCER RESEARCH (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells
TA Stadheim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production
T Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
